logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Coupon and Savings
    3. PAF Co-Pay Relief: HIV, AIDS and Prevention

    PAF Co-Pay Relief: HIV, AIDS and Prevention

    Not Funded
    About
    The PAF Co-Pay Relief: HIV, AIDS and Prevention program offers essential financial benefits for patients needing assistance with co-payments for a wide range of HIV and AIDS related medications. The program provides immediate funding upon approval, offering coverage for numerous drugs such as Atripla, Complera, Edurant, and many more. Designed to alleviate the financial burden for insured patients with FDA-approved treatments, this program is committed to supporting patients by requiring a simple income verification process and coverage confirmation, making it an invaluable resource for those meeting the eligibility criteria.
    Insurance requirements: Commercially insured, Medicare / Medicaid
    Enrollment Forms
    Enrollment Form
    Benefits
    •$5000 annual maximum benefit
    Program Requirements
    •Valid only for residents in the US and Puerto Rico
    •Enrollment Required: Yes
    •Coverage Required: No
    •Needs Based: Yes
    •Activation Required: No
    Program Details
    •Specific drug coverage is not indicated on program website; drug coverage must be verified by calling program at 18665123861
    •Patients may complete the application online or by phone; once approved, patients will begin receiving funding immediately
    •All patients approved for assistance are required to have their diagnosis and treatment verified by a member of the patient’s care team within 30 days of approval
    •The CoPay Relief Program will confirm the patient's reported income to ensure that it is within the income eligibility guidelines for the program through an income verification screening process
    •If patient's reported income is unable to be verified, a letter will be sent requesting proof of income documents be submitted to our program within 30 days for continued eligibility. Approved patients who do not comply with the request for income documentation within 30 days will forfeit their award
    •Approved patients who have a household income in excess of program guidelines upon review of submitted income documentation will no longer qualify for continued support, will forfeit their award and will not be eligible to reapply for the program until 12 months from the original date of approval
    •Approved patients understand and agree that if they do not comply with the request for income documentation will no longer qualify for continued support, will forfeit their award and will not be eligible to reapply for the program until 12 months from the original date of approval
    •Patients can continue to submit claims for payment during this income verification period
    •Claims can be submitted to CPR for payment via Virtual Pharmacy Card, electronic upload into the portal, faxed using the unique barcoded fax cover sheet or mailed
    •Claims can be paid via Virtual Pharmacy Card, Electronic Funds Transfer (EFT) or check
    •Approved patients who exceed 120 days with no processed claims at any time during their 12 month award period will forfeit their award. Patients who forfeit their award due to lack of utilization are not eligible to reapply for the program until 12 months from the original date of approval. Uninsured patients are ineligible UNLESS they have had coverage within the previous 6 months
    •Foundation covers all drugs that are FDAindicated for the diagnosis. If physician prescribes an offlabel medication, and the insurance company will pay for it, the foundation will also cover it
    Enrollment Forms
    Enrollment Form